東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Proteomics and metabolomics in psych...

Martins-de-Souza, Daniel.

FindBook

Google Book

Amazon

博客來

Proteomics and metabolomics in psychiatry

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Proteomics and metabolomics in psychiatry/ volume editor, Daniel Martins-de-Souza.
其他作者:	Martins-de-Souza, Daniel.
出版者:	Basel :S. Karger AG, : 2014.,
面頁冊數:	1 online resource (vii, 142 p.) :ill.
內容註:	Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T.
標題:	Mental illness - Etiology. -
電子資源:	http://www.karger.com/Book/Home/261475
ISBN:	9783318026009 (electronic bk.)

Proteomics and metabolomics in psychiatry
Proteomics and metabolomics in psychiatry[electronic resource] /volume editor, Daniel Martins-de-Souza. - Basel :S. Karger AG,2014. - 1 online resource (vii, 142 p.) :ill. - Advances in biological psychiatry,Vol. 290378-7354 ;. - Advances in biological psychiatry ;v.25..

Includes bibliographical references and index.

Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T.

ISBN: 9783318026009 (electronic bk.)Subjects--Topical Terms:

526580
Mental illness
--Etiology.

LC Class. No.: RC454.4 / .P76 2014eb

Dewey Class. No.: 616.89

National Library of Medicine Call No.: W1 / AD44 v.29 2014

Proteomics and metabolomics in psychiatry
LDR:02235cmm a2200313Ka 4500 001 2006121
003 OCoLC
005 20151214090334.0
006 m o d
007 cr cnu---unuuu
008 160114s2014 sz a ob 001 0 eng d
020 $a 9783318026009 (electronic bk.)
020 $a 331802600X (electronic bk.)
020 $z 9783318025996
020 $z 3318025992
035 $a (OCoLC)882106770 $z (OCoLC)889313143
035 $a ocn882106770
040 $a N $b eng $c N $d IDEBK $d UIU $d UKSKG $d YDXCP $d CDX $d OCLCF $d NLGGC $d E7B $d EBLCP
050 4 $a RC454.4 $b .P76 2014eb
060 1 4 $a W1 $b AD44 v.29 2014
060 1 4 $a WM 140
082 0 4 $a 616.89 $2 23
245 0 0 $a Proteomics and metabolomics in psychiatry $h [electronic resource] / $c volume editor, Daniel Martins-de-Souza.
260 $a Basel : $b S. Karger AG, $c 2014.
300 $a 1 online resource (vii, 142 p.) : $b ill.
490 1 $a Advances in biological psychiatry, $x 0378-7354 ; $v Vol. 29
504 $a Includes bibliographical references and index.
505 0 $a Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients / Caf-Mendes, C.C.; Gattaz, W.F.; Schmitt, A.; Britto, L.R.G.; Martins-de-Souza, D -- Peripheral biomarker candidates in schizophrenia / Thome, J.; Bratek, A.; Krysta, K -- Schizophrenia : blood-serum-plasma metabolomics / Lista, S.; Giegling, I.; Rujescu, D -- Proteomic and metabolomic evidence for glial alterations in schizophrenia / Beasley, C.L.; Barakauskas, V.E -- Insights from proteomic studies on schizophrenia preclinical models : what can we learn for drug discovery? / Farrelly, L.A.; Föcking, M.; Cotter, D.R -- Metabolomics to study psychotic disorders and their metabolic comorbidities / Oresi, M -- Peripheral biomarkers for depression by plasma and serum proteomics / Domenici, E -- Proteomics of preclinical models of depression / Carboni, L -- Antidepressant response metabonomics / Qin, X.; Gao, X.; Qiao, Y.; Zhou, Y.; Tian, J.; Li, Z -- Proteomics and metabolomics of bipolar disorder / Sussulini, A -- Use of metabolomics and proteomics to reveal pathophysiological pathways in anxiety disorders / Altmaier, E.; Emeny, R.T.
588 $a Description based on print version record.
650 0 $a Mental illness $x Etiology. $3 526580
650 2 $a Mental Disorders $x etiology. $3 591092
650 2 $a Biological Markers. $3 572611
650 2 $a Mental Disorders $x diagnosis. $3 524297
650 2 $a Mental Disorders $x physiopathology. $3 613004
650 2 $a Metabolomics $x methods. $3 2152850
650 2 $a Proteomics $x methods. $3 600681
700 1 $a Martins-de-Souza, Daniel. $3 2152849
830 0 $a Advances in biological psychiatry ; $v v.25. $3 1360782
856 4 0 $u http://www.karger.com/Book/Home/261475